CTSI Profile Photo
George Rutherford, MD
User Profile Name
Professor, School of Medicine
CTSI Profile Title
Email: George.Rutherford@ucsf.edu
User Profile Email
Biography
My research interests are the epidemiology and prevention of infectious and tropical diseases of public health importance, both internationally and domestically, with a primary focus on HIV and AIDS. My work is funded primarily by the Centers for Disease Control and Prevention through the Presidential Emergency Plan for AIDS Relief. I also have smaller projects dealing with the epidemiology of tuberculosis in California, the prevention of childhood injury, immunizations and bioterrorism. I am a member of the AIDS Research Institute's Executive Committee.
CTSI Profile Bio
Displaying 76 - 100 of 274
- Penn AW, Azman H, Horvath H, Taylor KD, Hickey MD, Rajan J, Negussie EK, Doherty M, Rutherford GW. Supportive interventions to improve retention on ART in people with HIV in low- and middle-income countries: A systematic review. PLoS One. 2018; 13(12):e0208814.
- Ngeno B, Waruru A, Inwani I, Nganga L, Wangari EN, Katana A, Gichangi A, Mwangi A, Mukui I, Rutherford GW. Disclosure and Clinical Outcomes Among Young Adolescents Living With HIV in Kenya. J Adolesc Health. 2019 02; 64(2):242-249.
- Awotiwon AA, Johnson S, Rutherford GW, Meintjes G, Eshun-Wilson I. Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people. Cochrane Database Syst Rev. 2018 08 29; 8:CD004773.
- Kelly JD, Hickey MD, Schlough GW, Conteh S, Sesay M, Rutherford GW, Giordano TP, Weiser SD. Understanding why HIV-infected persons disengaged from pre-ART care in Freetown, Sierra Leone: a qualitative study. AIDS Care. 2018 Aug 26; 1-4.
- Cummings B, Horth R, McFarland W, Lane T, Young PW, Nalá R, Rutherford G, Raymond HF. Bisexual and Bidirectional: Assessing the Potential for HIV Bridging in Mozambique. AIDS Behav. 2018 Jul; 22(7):2189-2198.
- Aguilar G, Miranda AE, Rutherford GW, Munoz S, Hills N, Samudio T, Galeano F, Kawabata A, González CMR. Mortality Rate and Predictors in Children Under 15 Years Old Who Acquired HIV from Mother to Child Transmission in Paraguay. AIDS Behav. 2018 Jul; 22(Suppl 1):99-104.
- Hudson M, Rutherford GW, Weiser S, Fair E. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review. PLoS One. 2018; 13(4):e0194960.
- Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, Reniers G, Todd J, Schwarcz S, Weir S, Rutherford G, Hargreaves J. Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa. JMIR Public Health Surveill. 2018 Apr 03; 4(2):e36.
- Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Drasher M, Schlough GW, Dierberg K, Koedoyoma S, Lindan CP, Jones JH, Chamie G, Worden L, Greenhouse B, Weiser SD, Porco TC, Rutherford GW, Richardson ET. Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16. J Infect Dis. 2018 Mar 28; 217(8):1214-1221.
- Kelly JD, Richardson ET, Drasher M, Barrie MB, Karku S, Kamara M, Hann K, Dierberg K, Hubbard A, Lindan CP, Farmer PE, Rutherford GW, Weiser SD. Food Insecurity as a Risk Factor for Outcomes Related to Ebola Virus Disease in Kono District, Sierra Leone: A Cross-Sectional Study. Am J Trop Med Hyg. 2018 Mar 19.
- Ng'eno BN, Kellogg TA, Kim AA, Mwangi A, Mwangi M, Wamicwe J, Rutherford GW. Modes of HIV transmission among adolescents and young adults aged 10-24 years in Kenya. Int J STD AIDS. 2018 07; 29(8):800-805.
- Razani N, Morshed S, Kohn MA, Wells NM, Thompson D, Alqassari M, Agodi A, Rutherford GW. Effect of park prescriptions with and without group visits to parks on stress reduction in low-income parents: SHINE randomized trial. PLoS One. 2018; 13(2):e0192921.
- Chaba DCDS, Soares LR, Pereira RMR, Rutherford GW, Assone T, Takayama L, Fonseca LAM, Duarte AJS, Casseb J. Low bone mineral density among HIV-infected patients in Brazil. Rev Inst Med Trop Sao Paulo. 2017 Dec 21; 59:e89.
- Pollett S, Althouse BM, Forshey B, Rutherford GW, Jarman RG. Internet-based biosurveillance methods for vector-borne diseases: Are they novel public health tools or just novelties? PLoS Negl Trop Dis. 2017 Nov; 11(11):e0005871.
- Khatib A, Matiko E, Khalid F, Welty S, Ali A, Othman A, Haji S, Dahoma M, Rutherford G. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar. BMC Public Health. 2017 11 28; 17(1):917.
- Rutherford GW, Geng E. Supplementary antimicrobials for patients with HIV and <100 CD4 cells/µL are associated with improved survival. Evid Based Med. 2017 12; 22(6):209.
- Balayan T, Horvath H, Rutherford GW. Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review. AIDS Res Treat. 2017; 2017:2345617.
- Twigg HL, Crystal R, Currier J, Ridker P, Berliner N, Kiem HP, Rutherford G, Zou S, Glynn S, Wong R, Peprah E, Engelgau M, Creazzo T, Colombini-Hatch S, Caler E. Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research. AIDS Res Hum Retroviruses. 2017 Sep; 33(9):889-897.
- Rutherford GW, Anglemyer A. Is 90-90-90 achievable? Lancet HIV. 2017 05; 4(5):e193-e194.
- Mbuagbaw L, Mursleen S, Irlam JH, Spaulding AB, Rutherford GW, Siegfried N. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Cochrane Database Syst Rev. 2016 12 10; 12:CD004246.
- Rutherford GW, Anglemyer A. Early initiation of antiretroviral therapy prevents HIV transmission to seronegative sexual partners. Evid Based Med. 2017 03; 22(1):29.
- Richardson ET, Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Marsh RH, Koedoyoma S, Daboh F, Barron KP, Grady M, Tucker E, Dierberg KL, Rutherford GW, Barry M, Jones JH, Murray MB, Farmer PE. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey. PLoS Negl Trop Dis. 2016 11; 10(11):e0005087.
- Rutherford GW, Horvath H. Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review. PLoS One. 2016; 11(10):e0162775.
- Razani N, Kohn MA, Wells NM, Thompson D, Hamilton Flores H, Rutherford GW. Design and evaluation of a park prescription program for stress reduction and health promotion in low-income families: The Stay Healthy in Nature Everyday (SHINE) study protocol. Contemp Clin Trials. 2016 11; 51:8-14.
- Pollett S, Boscardin WJ, Azziz-Baumgartner E, Tinoco YO, Soto G, Romero C, Kok J, Biggerstaff M, Viboud C, Rutherford GW. Evaluating Google Flu Trends in Latin America: Important Lessons for the Next Phase of Digital Disease Detection. Clin Infect Dis. 2017 Jan 01; 64(1):34-41.